← Back to Search
Tricyclic Antidepressant
Amitriptyline for Migraine (RCTVM Trial)
Nashville, TN
Phase < 1
Waitlist Available
Led By Richard A Roberts, PhD
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
English-speaking adults
Diagnosed with Definite Vestibular Migraine
Must not have
Already using amitriptyline
Non-English speaking
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30, 60, 90 days and 1 year
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to study the effects of amitriptyline medication and lifestyle modifications on reducing symptoms of dizziness and headache in patients with vestibular migraine. The study will randomly assign participants to either
See full description
Who is the study for?
This trial is for individuals who experience vestibular migraine, which includes symptoms like vertigo, nausea, and balance issues. Participants must be diagnosed with VM to join the study. The trial will involve a random assignment to either take the medication Amitriptyline or engage in lifestyle modifications.Check my eligibility
What is being tested?
The study aims to compare the effectiveness of Amitriptyline against lifestyle changes in reducing dizziness and headache symptoms associated with vestibular migraine. Progress will be tracked using specific inventories for dizziness (DHI) and headaches (HDI), at intervals up to one year.See study design
What are the potential side effects?
Amitriptyline may cause side effects such as dry mouth, constipation, blurred vision, sleepiness, weight gain or loss, and potentially more serious heart-related issues. Lifestyle modification typically has fewer risks but may include challenges adapting new habits.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am an adult who speaks English.
show original
Select...
I have been diagnosed with vestibular migraine.
show original
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am currently taking amitriptyline.
show original
Select...
I do not speak English.
show original
Select...
I am currently being treated for Meniere's disease.
show original
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 30, 60, 90 days and 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30, 60, 90 days and 1 year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Dizziness
Change in Headache
Side Effects
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Active Control
Group I: Lifestyle ModificationActive Control1 Intervention
Written and video instructions to help improve restful sleep, mealtime regularity, avoidance of dietary triggers, and exercise for 90 days.
Group II: AmitriptylineActive Control1 Intervention
amitriptyline, tablet, 25 mg, once daily, 90 days
Find a Location
Closest Location:Vanderbilt University Medical Center· Nashville, TN
Who is running the clinical trial?
Vanderbilt University Medical CenterLead Sponsor
919 Previous Clinical Trials
938,646 Total Patients Enrolled
1 Trials studying Migraine
Richard A Roberts, PhDPrincipal InvestigatorVanderbilt University Medical Center